Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/41597
| Title: | Gemcitabine and Hemolytic Uremic Syndrome: a Case Report | Authors: | Villalba, Noel Lorenzo Merzouki, Tawoufik Sablón González, Nery Alonso Ortiz, María Belén Kechida, Melek Bailon, M. M Fuertes Zamorano, Nuria Saint-Mezard, Vanessa Teguo, M. T. |
UNESCO Clasification: | 320507 Neurología 320504 Hematología |
Keywords: | Hemolytic uremic syndrome Gemcitabine Renal failure |
Issue Date: | 2017 | Journal: | Journal of Blood and Lymph | Abstract: | We are reporting the case of a 61 year old male patient with a medical history of pancreatic cancer on chemotherapy presenting a uremic hemolytic syndrome after the administration of gemcitabine. The renal function progressively worsened during his stay in spite of general measures and steroids, leading to the death at day 12 of admission. | URI: | http://hdl.handle.net/10553/41597 | ISSN: | 2165-7831 | DOI: | 10.4172/2165-7831.1000168 | Source: | Journal of Blood and Lymph [ISSN 2165-7831], v. 7 (2), p. 168 |
| Appears in Collections: | Artículos |
Adobe PDF (330,81 kB)
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.